Effect of survivin antisense oligodeoxynucleotide on proliferation and apoptosis of human malignant melanoma cells

Chinese Journal of Burns

Volumn 26, Issue 2, 2010, Pages 128-132

  Cao, Yong Qian ^a   Wang, Fa Gang ^a   Huo, Ran ^a   Cai, Jing Long ^a   Feng, Yong Qiang ^a   Li, Qiang ^a   Wang, Yi Bing ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Caspase 3; Melanoma; Oligonucleotides, antisense; Survivin

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE 3; LIPOSOME; MESSENGER RNA; SURVIVIN;

ANTISENSE THERAPY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MELANOMA CELL; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MELANOMA; MICROTUBULE-ASSOCIATED PROTEINS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; TRANSFECTION;

EID: 77954120542     PISSN: 10092587     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1009-2587.2010.02.013     Document Type: Article

References (9)

1. Rödel F, Frey B, Leitmann W, et al. Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models. Int J Radiat Oncol Biol Phys, 2008,71(1):247-255. (Pubitemid 351491424)
2. Yamamoto H, Ngan CY, Monden M. Cancer cells survive with survivin. Cancer Sci, 2008,99(9):1709-1714.
3. Mesri M, Wall NR, Li J, et al. Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest, 2001,108(7):981-990. (Pubitemid 32946072)
4. Gradilone A, Gazzaniga P, Ribuffo D, et al. Survivin, bcl-2, bax, and bcl-x gene expression in sentinel lymph nodes from melanoma patients. J Clin Oncol, 2003,21(2):306-312.
5. Liu T, Brouha B, Grossman D. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene, 2004,23( 1):39-48. (Pubitemid 38142238)
6. Miyake H, Hara I, Fujisaw M, et al. Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects. Expert Rev Anticancer Ther, 2005,5(6):1001-1009. (Pubitemid 43033790)
7. Mita AC, Mita MM, Nawrocki ST, et al. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res, 2008,14(16):5000-5005.
8. Tan M, Gallegos JR, Gu Q, et al. SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection. Neoplasia, 2006,8(12):1042-1054.
9. Colnaghi R, Connell CM, Barrett RM, et al. Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem, 2006,281(44):33450-33456. (Pubitemid 46036726)